Aptamers as tools for target validation
- 11 July 2005
- journal article
- review article
- Published by Elsevier in Current Opinion in Chemical Biology
- Vol. 9 (4), 336-342
- https://doi.org/10.1016/j.cbpa.2005.06.011
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- The potential of aptamers as anticoagulantsTrends in Cardiovascular Medicine, 2005
- Oligo oligarchy—the surprisingly small world of aptamersNature Biotechnology, 2004
- Photoaptamer arrays applied to multiplexed proteomic analysisProteomics, 2004
- Neutralization of Infectivity of Diverse R5 Clinical Isolates of Human Immunodeficiency Virus Type 1 by gp120-Binding 2′F-RNA AptamersJournal of Virology, 2003
- Small Interfering RNAs: A Revolutionary Tool for the Analysis of Gene Function and Gene TherapyMolecular Interventions, 2002
- PRECLINICAL AND PHASE 1A CLINICAL EVALUATION OF AN ANTI-VEGF PEGYLATED APTAMER (EYE001) FOR THE TREATMENT OF EXUDATIVE AGE-RELATED MACULAR DEGENERATIONRetina, 2002
- Functional organization of the yeast proteome by systematic analysis of protein complexesNature, 2002
- RNA aptamers as pathway-specific MAP kinase inhibitorsChemistry & Biology, 2000
- In vitro selection of RNA molecules that bind specific ligandsNature, 1990
- Systematic Evolution of Ligands by Exponential Enrichment: RNA Ligands to Bacteriophage T4 DNA PolymeraseScience, 1990